Fantastic summary. Clinicians often underestimate the impact of lifelong poly pharmacy - “you say treatment, I say hard work!”. HER-SAFE will address GDMT withdrawal in breast cancer survivors with HFimpEF following antiHER cardiac dysfunction. Recruitment finishing soon!
In #JACCHF, Drs. Nandan Kodur & @WilsonTangMD review management of #HFimpEF
🔸Who must continue #GDMT?
🔸What are characteristics of those who may be able to withdraw?
🔸Where are the evidence gaps?
🔸What are areas for future study
🔗: jacc.org/doi/10.1016/j.…View quoted post on X
